Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-16, Stock:LLY, The news for the past five days is as follows:
2018-01-08: NEWS1: Eli Lilly CEO Says Tax Reform May Lead to More Successful Deals.NEWS2: Pfizer to Stall R&D for Alzheimer's/Parkinson's, Cut Jobs.NEWS3: Celgene deal could be the first of many for biopharma as new tax law frees up cash.NEWS4: Eli Lilly CEO: It's a great time for science in pharma se....NEWS5: Alzheimer's takes Another Hit as Pfizer Ends Research in this Area.NEWS6: Pfizer to Stall R&D for Alzheimer&apos;s/Parkinson&apos;s, Cut Jobs.NEWS7: Ozempic Could Boost Novo Nordisk’s Revenue Growth in 2018.NEWS8: Livongo and Lilly Collaborate on Real-World Diabetes Research.NEWS9: Alzheimer&apos;s takes Another Hit as Pfizer Ends Research in this Area.
2018-01-09: NEWS1: Ignyta’s Drug Pipeline.NEWS2: Health secretary nominee indicates support for Medicaid overhaul.NEWS3: Trump health pick wary of government drug price negotiations.NEWS4: Eli Lilly CEO on Drug Pricing and Diabetes Treatment.NEWS5: How Was Incyte’s Revenue Stream in 3Q17?.NEWS6: Eli Lilly CEO Says Drug Pricing Innovation Is Needed.NEWS7: Why AbbVie Is Focused on Expanding Risankizumab’s Label for Multiple Immunology Indications.NEWS8: Examining Incyte’s Quarterly Revenue Trend.NEWS9: Eli Lilly To Present At J.P. Morgan Healthcare Conference; Webcast At 7:00 PM ET.NEWS10: Eli Lilly To Present At J.P. Morgan Healthcare Conference; Webcast At 7:00 PM ET.NEWS11: FDA Approvals Surge in 2017: Here's a Look at the Numbers.NEWS12: The 1 Word That Explains Why Pfizer's Future Looks Brighter Than Its Past.NEWS13: Despite Setbacks, Drugmakers Have Plans to Fight Alzheimer’s.NEWS14: Drug Industry Isn't Giving Up on Alzheimer's.
2018-01-10: NEWS1: Eli Lilly & Co. at J.P. Morgan: 5 Things Investors Will Want to Know.NEWS2: Eli Lilly & Co. at J.P. Morgan: 5 Things Investors Will Want to Know.
2018-01-11: NEWS1: Elanco Announces Addition of New North America and Global Strategy Senior Executive.NEWS2: Big Pharma CEOs Speak About Impact of Tax Reform on M&A.NEWS3: How Mylan’s Rest of the World Segment Performed in 3Q17.NEWS4: Elanco, Aratana Announce Marketing Authorization of GALLIPRANT® (grapiprant tablets) in Europe.
2018-01-12: NEWS1: Three Diabetes Clinical Trials to Watch in 2018.NEWS2: Merck's Keytruda on a Roll: Can it Retain the Spark in 2018?.NEWS3: Lilly's Elanco/Aratana's Veterinary Medicine Gets EU Nod.NEWS4: Dow 30 Stock Roundup: Boeing Q4 Deliveries Up Y/Y, Success for Merck's Keytruda Combo.NEWS5: Lilly&apos;s Elanco/Aratana&apos;s Veterinary Medicine Gets EU Nod.NEWS6: Wall Street Recommendations for Mylan in January 2018.

Answer: Decrease